Historical record - last NADAC effective date: 11/18/2020
Product Information
MOMETASONE FUROATE 0.1% SOLN is a generic product labeled by Sun Pharmaceutical Industries Inc., priced at $0.3672 per ML under NDC 51672130504. Its NADAC has been published 367 times since Nov 28, 2013.
FDA first approved this application on Mar 15, 2006.
Strength
1 mg/mL
Manufacturer
Sun Pharmaceutical Industries Inc.NDC
51672130504
Classification
Generic
Dosage Form
SOLUTION
Route
TOPICAL
Effective Date
11/18/2020
Active Ingredients
MOMETASONE FUROATEApproval Type
Generic (ANDA)
FDA Application
ANDA076788FDA Approved
3/15/2006
On Market Since
3/15/2006
Pharmacological Classes
Price Statistics
The NADAC for MOMETASONE FUROATE 0.1% SOLN has been published 367 times since Nov 28, 2013, and over the history we have for it it has risen 57.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3672 per ML |
|---|---|
| All-time high | $0.3748 (Jun 12, 2019) |
| All-time low | $0.1734 (Dec 20, 2017) |
| Median price | $0.2066 |
| Average price | $0.2415 |
| Largest weekly change | -41.5% (Feb 19, 2014) |
| Weeks tracked | 367 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
+57.0%
Last surveyed Dec 2, 2020 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Sun Pharmaceutical Industries Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Mometasone Furoate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Corticosteroid class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of MOMETASONE FUROATE 0.1% SOLN?
The current National Average Drug Acquisition Cost (NADAC) for MOMETASONE FUROATE 0.1% SOLN, manufactured by Sun Pharmaceutical Industries Inc., is $0.3672 per ML (NDC 51672130504), effective Dec 2, 2020.
How has the price of MOMETASONE FUROATE 0.1% SOLN changed over time?
Over the history we have for it, the NADAC for MOMETASONE FUROATE 0.1% SOLN has risen 57.0%. It has been tracked across 367 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for MOMETASONE FUROATE 0.1% SOLN?
Since Nov 28, 2013, the NADAC for MOMETASONE FUROATE 0.1% SOLN has ranged from a low of $0.1734 (Dec 20, 2017) to a high of $0.3748 (Jun 12, 2019), with a median of $0.2066 per ML.
Are there cheaper alternatives to MOMETASONE FUROATE 0.1% SOLN?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as MOMETASONE FUROATE 0.1% SOLN in a comparable dosage form, but none are currently priced below it.
Who manufactures MOMETASONE FUROATE 0.1% SOLN?
MOMETASONE FUROATE 0.1% SOLN (NDC 51672130504) is labeled by Sun Pharmaceutical Industries Inc., and CMS classifies it as a generic product.